Metrorrhagia: A Rare Manifestation of Anaphylaxis Induced by Allergen Immunotherapy

Authors

  • Maria Ntakoula
  • Christos Fokoloros
  • Caterina Chliva
  • Evangelia Papadavid
  • Michael Makris

Abstract

Allergen specific immunotherapy is the only disease-modifying treatment for allergic rhinoconjuctivitis and asthma. We present a rare clinical case of metrorrhagia as the major manifestation of anaphylaxis induced by subcutaneous immunotherapy to inhalant allergens.

Downloads

Published

2020-07-08

How to Cite

Ntakoula, M., Fokoloros, C., Chliva, C., Papadavid, E., & Makris, M. (2020). Metrorrhagia: A Rare Manifestation of Anaphylaxis Induced by Allergen Immunotherapy. Archives of Clinical and Medical Case Reports, 4(4), 619–623. Retrieved from https://fortunejournals.org/ojs/index.php/acmcr/article/view/22354

Issue

Vol. 4 No. 4 (2020): Volume 4, Issue 4

Section

Articles